Cannabidiol as a putative novel therapy for diabetic retinopathy: A postulated mechanism of action as an entry point for biomarker-guided clinical development

G. I. Liou, A. B. El-Remessy, A. S. Ibrahim, R. B. Caldwell, Y. M. Khalifa, A. Gunes, J. J. Nussbaum

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Cannabidiol as a putative novel therapy for diabetic retinopathy: A postulated mechanism of action as an entry point for biomarker-guided clinical development'. Together they form a unique fingerprint.

Medicine & Life Sciences